Industry Funding Opportunities

January 20, 2022

Boehringer Ingelheim’s (BI) Request for Proposal to Characterize human hepatocyte response to NASH/fibrotic ECM

Submission Deadline: March 22, 2022

Proposals invited to identify new potential therapeutic targets for late-stage NASH or to develop methods that enable identification of such targets...

December 8, 2021

Improving Detection of Neurotoxicity in Immunotherapies QuickFire Challenge

Submission Deadline: March 18, 2022

To inspire early identification of neurotoxicity, Johnson & Johnson Innovation, together with Janssen Global Services, is proud to launch the...

December 6, 2021

Advanced Materials for the Generation of Bio-Based Products via Immobilised Non-Mammalian Organisms

Submission Deadline: January 24, 2022

A privately held, US headquartered, multinational materials science company (>$4B revenue) focused on discovery and product innovation is seeking...

November 29, 2021

J&J Food Allergy Prevention Quick Fire Challenge

Submission Deadline: February 18, 2022

Innovators are invited to submit novel methods, products, or technologies with the potential to prevent children from developing food allergy in the...

November 23, 2021

Daiichi Sankyo Request for Proposals

Submission Deadline: February 28, 2022

Daiichi Sankyo Modality Collaboration

Drug discovery research with Daiichi Sankyo original nucleic acid therapeutics:

November 9, 2021

J&J Nurses Innovate QuickFire Challenge

Submission Deadline: February 4, 2022

Johnson & Johnson Nurses Innovate QuickFire Challenge series continues with “...

May 14, 2021

Partnership with BridgeBio on Genetic Diseases

The University of Pittsburgh has launched a new partnership with BridgeBio to accelerate the development of breakthrough therapies for genetic diseases and...